What your wrist will measure in 2030, and what it can never be

What your wrist will measure in 2030, and what it can never be
DO

David Ohayon

Founder & CEO, Smartlet - CentraleSupelec engineer - Concours Lepine 2025, Awarded - CES 2026

The wearable on your wrist is quietly turning into a medical device. The watch above it is quietly turning into nothing new at all. That gap, between the half that keeps gaining sensors and the half that deliberately gains nothing, is about to become the most interesting thing on your arm. Most people read the sensor roadmap as a story about technology. It is at least as much a story about lawyers, regulators and the stubborn physics of human skin.

Key takeaways
  • Blood oxygen. Pulled then re-architected to run on the paired iPhone; the trade dispute closed in April 2026. A feature can vanish by lawsuit, not physics.
  • Blood pressure. Current watchOS flags hypertension patterns over 30 days as an alert, not a number. The wrist screens, it does not diagnose.
  • Glucose. The holy grail: 15+ years in, still a proof of concept the size of a phone, realistic around 2028 to 2030, no watch authorised to measure it alone.
  • The pattern. Sensor progress is gated by physics, regulation and litigation, and each step makes the wearable more clinical and more about your body.
  • The reversal. The more clinical the wearable becomes, the less it can be an heirloom, which is the strongest case for keeping two objects on one wrist.

Three sensors, three different kinds of wall

Let me walk the roadmap, because the obstacles are more revealing than the features. Start with blood oxygen, because it is the cautionary tale. The feature shipped, worked, and then vanished from new watches in the United States, not for any technical reason but because of a patent fight with Masimo. It came back only after the calculation was moved off the watch and onto the paired iPhone, a redesign rather than an improvement, and the trade dispute around it was finally closed in April 2026. The lesson is uncomfortable for anyone who thinks sensors only ever move forward: a working feature on your wrist can disappear by court order and return in a different shape.

Then take blood pressure, which is already here in a careful, half-finished form. Recent watchOS software can flag signs of chronic hypertension from the optical heart sensor by watching your readings across thirty days. Notice what it does and does not do. It raises an alert that says you might have a problem; it does not show you a number. That restraint is not Apple being shy. It is what clearance from the regulator allows today, and it tells you the shape of the near future: the wrist will screen, then send you to a cuff and a doctor, long before it dares to diagnose.

Sleep apnea followed the same pattern, detected through movement and breathing disturbance rather than a clean clinical reading, an alert that nudges you toward a real test. The pattern repeats because the rules require it. You can see the same screen-not-diagnose line in how the wearable handles an ECG you then take to a cardiologist.

The holy grail, still distant

Non-invasive blood glucose, reading sugar through the skin with no needle, has run for more than fifteen years, and the working proof of concept is reportedly still a device the size of a phone strapped to the upper arm. Honest timelines put a wrist version around 2028 to 2030, and the regulator has authorised no smartwatch or ring to measure glucose on its own.

The pattern, and the part nobody likes to say

Stand back and the future of wrist sensors is gated by three things at once. Physics, because glucose through skin is genuinely hard. Regulation, because the wrist is allowed to alert but rarely to diagnose. And litigation, because a feature can be worth fighting over in court. Progress is real, but it is throttled, and every step pushes the wearable further in one direction: more clinical, more regulated, more medical, more about your body as a set of readings.

As the wearable gets better at being a clinic, it gets no closer to being a watch. The two roles do not converge. They pull apart.

The more the wearable becomes a medical instrument, the less it can also be the other thing a wrist has always carried. A device that is busy screening you for hypertension and chasing your glucose is not an heirloom, and it is not trying to be. Meaning, continuity, the object you hand to your daughter, the dial you stare at for no functional reason, none of that is on the sensor roadmap, because none of it can be measured.

So the honest conclusion runs against the usual one. The future of sensors is not an argument for replacing your watch with a smarter one. It is the strongest argument yet for keeping two objects on the wrist, because you want the clinical half and the human half, and you specifically do not want the clinical half to be the thing with your grandfather's name on the caseback. There is a deeper way to read the split, and it is about time, not medicine. The wearable measures your body because it assumes it will be obsolete; the watch carries your story because it assumes it will outlive you. One is a fast object of software, updates and replacement. The other is a slow object of permanence, repair and inheritance. A dual-wear setup is simply the bridge between the two.

How you actually adopt the future

There is a quiet, practical bonus to this. Every sensor on that roadmap arrives by replacing the wearable, never the watch. When the 2030 glucose reader finally ships, you will buy the new band and swap it in. The mechanical watch on top does not move, does not update, does not get dropped by an operating system, does not care. That is the logic of a modular setup: the disposable, fast-moving, medical half rides underneath and gets renewed on its own schedule, while the object built to age sits above it and simply continues.

The same instinct that makes collectors keep the watch and add the sensor rather than trade one for the other is, it turns out, also the smartest way to stay current. You can already feel the split in what each side does best, the ECG and the HRV the wearable tracks against a watch that, by design, will never measure a thing. Whether you treat that as a deliberate composition or a quiet rebellion, the structure is the same: a watch that holds its meaning on top, a sensor that holds the future underneath, on one strap.

If you want to see what reaches the wrist today, the Apple Watch compatibility page and the brand index are the place to start, and the collection shows the three editions that carry the pairing.

The real architecture

By 2030 your wrist may screen for glucose, blood pressure, sleep apnea and conditions we cannot yet name. Every one of those sensors will be replaced by a better one. The object above them may never be replaced at all. One half of the wrist keeps updating. The other keeps accumulating meaning. That was always the real architecture.


Questions

Frequently asked questions

Smartlet One

Choose your dual-wear strap.

One patented mechanism. Three expressions in steel, black, and titanium.

Smartlet One - Shadow - Smartlet

For the explorer

Smartlet One - Shadow

€399,00

4.9 (15)

Stealth. Switch in seconds, leave no trace.

  • Material SS316L steel, black PVD
  • Weight ~100g
  • Compatible with Rolex, Omega, Seiko + 100 more
Buy now